Physician Profile

Dale Schaar, MD, PhD
Medical Oncologist

I have been at Rutgers Cancer Institute of New Jersey since 2002 having completed a fellowship in medical oncology here, which was preceded by my residency in Internal Medicine at the University of Maryland. 

I specialize in the care of patients with blood cell cancers with a focus on the myeloid disorders including acute leukemia and myelodysplastic syndromes. In addition, I am one of the stem cell transplant physicians here at the Cancer Institute and therefore, am able to provide all levels of treatment that may be required for these disorders. I am able to provide patients with a comprehensive evaluation -- and through consultation with the multidisciplinary teams within the Leukemia/Lymphoma/Hematologic Malignancies and Stem Cell Transplantation Programs, I help educate patients on their treatment options so that they can make an informed decision.

I have a research interest in the molecular basis of acute myelogenous leukemia (AML) and am currently exploring novel genes for their use as biomarkers and potential treatment targets to improve the care of patients with these blood cell cancers.  And by having the resources available that can only be found at a National Cancer Institute-designated Comprehensive Cancer Center, our team is able to translate these research findings and directly apply them to patient therapies. 

I am the author or co-author of numerous publications and serve as the principal or co-investigator on several ongoing clinical trials for patients with blood cell cancers.

Clinical Expertise 

Hematologic malignancies, bone marrow transplants, leukemia, lymphoma, blood cancers

Contact Information  

To schedule a new patient appointment call 732-235-8515.
For all other inquiries call 732-235-2465.

image that says give now and support cancer research with link to giving page





Logo for ScreenNJ program and link to website





Robert Wood Johnson Barnabas Health logo with link to Partners page






Big Ten Cancer Research Consortium





Rutgers Health